Product correctly added to cart.

discount label
MDM2 Antagonist IV, Nutlin-3a
View 3D

Biosynth logo

MDM2 Antagonist IV, Nutlin-3a

CAS: 675576-98-4

Ref. 3D-ACB57698

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 28 Jun 2024

Product Information

Name:
MDM2 Antagonist IV, Nutlin-3a
Synonyms:
  • (-)-Nutlin 3
  • 2-Piperazinone, 4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-
  • 4-[[(4S,5R)-4,5-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydroimidazol-1-yl]carbonyl]piperazin-2-one
  • Nutlin-3a
  • Piperazinone, 4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-
  • Sml 0580
Description:

Nutlin-3a is a potent and selective inhibitor of the MDM2 protein, which is an important regulator of p53. Nutlin-3a was shown to be less toxic than other chemical inhibitors in a model system. Nutlin-3a has been shown to induce significant cytotoxicity in cancer cells, but not in normal cells. This may be due to its ability to activate the apoptosis pathway by inhibiting the expression of pro-survival proteins such as Bcl-2 and Akt.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
581.49 g/mol
Formula:
C30H30Cl2N4O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-ACB57698 MDM2 Antagonist IV, Nutlin-3a

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".